Sterling Capital Management LLC Edgewise Therapeutics, Inc. Transaction History
Sterling Capital Management LLC
- $7.74 Trillion
- Q3 2024
A detailed history of Sterling Capital Management LLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 75 shares of EWTX stock, worth $2,494. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75Holding current value
$2,494% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EWTX
# of Institutions
163Shares Held
97.8MCall Options Held
45.7KPut Options Held
13.1K-
Orbimed Advisors LLC San Diego, CA15MShares$500 Million9.45% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$296 Million3.32% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$200 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY5.84MShares$194 Million1.67% of portfolio
-
Novo Holdings Hellerup, G75.55MShares$185 Million10.36% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $2.1B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...